Otolaryngology - Head and Neck Surgery·Worcester, MA

UMass Chan Medical School

Signal lift8%64%+56 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
245–271
p10 – p90
Sample N
209
applicants this cycle
This cycle
no tracked aways yet
Match rate
1.0%
2 of 41 applicants
01Cohort funnelthis cycle
N = 209
Applied
209
100.0%
Invited
41
19.6%
Class size
2
1%
J-1 visaCategorical
Your fitUMass Chan Medical School Program

Create a free profile to see your personalized fit

Get started
Contact
CI
Program Director
Christopher John Ito, MD, MEd
Email director
FG
Program Coordinator
Frankenia Guzman
Email coordinator
Training sites5 hospitals · Worcester
  • 1
    UMass Memorial Health (University Campus)
    Worcester, MA
    Primary
  • 2
    UMass Chan Medical School
    Worcester, MA
    Sponsor
  • 3
    UMass Memorial Health (Memorial Campus)
    Worcester, MA
    Participant
  • 4
    UMass Memorial Health Care (Hahnemann Campus)
    Worcester, MA
    Participant
  • 5
    Boston Children's Hospital
    Boston, MA
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK245271
180205230255280

Level 2 CE data not available

Interview rates
US MD
23%
US DO
13%
US IMG
0%
Non-US IMG
0%
Applicant origin
In-state
70%
Out-of-state
17%
Interview prepOtolaryngology - Head and Neck Surgery
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add UMass Chan Medical School to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Otolaryngology - Head and Neck Surgery.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.